PT Hetzer Medical Indonesia Tbk (IDX:MEDS)
Indonesia · Delayed Price · Currency is IDR 74.00
-1.00 (-1.33%)
Sep 2, 2026, 2:17 PM WIB
IDX:MEDS Cash Flow Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -4,156 | -8,346 | -8,534 | -3,570 | 237.06 | 26,631 |
Depreciation & Amortization | 4,454 | 4,316 | 4,569 | 4,228 | 2,969 | 1,728 |
Other Operating Activities | -1,026 | 2,555 | 6,195 | 2,495 | -16,230 | -14,876 |
Operating Cash Flow | -727.01 | -1,475 | 2,230 | 3,152 | -13,023 | 13,484 |
Operating Cash Flow Growth | - | - | -29.25% | - | - | -72.30% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -2,998 | -1,256 | -275.84 | -6,084 | -17,971 | -27,008 |
Sale of Property, Plant & Equipment | 360.36 | 144.14 | 636.94 | - | 243.24 | 1 |
Cash Acquisitions | - | - | - | -3.78 | - | - |
Other Investing Activities | - | - | - | - | - | -712.5 |
Investing Cash Flow | -2,638 | -1,112 | 361.09 | -6,088 | -17,728 | -27,719 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 3,900 | - | - | - | 11,200 |
Short-Term Debt Repaid | - | - | - | - | - | -2,100 |
Long-Term Debt Repaid | - | -2,582 | -2,777 | -2,486 | -2,118 | -133.69 |
Total Debt Repaid | -3,629 | -2,582 | -2,777 | -2,486 | -2,118 | -2,234 |
Net Debt Issued (Repaid) | -576.33 | 1,318 | -2,777 | -2,486 | -2,118 | 8,966 |
Issuance of Common Stock | - | - | - | - | 36,830 | - |
Common Dividends Paid | - | - | - | - | - | -7,200 |
Other Financing Activities | 3,481 | 1,816 | -247.5 | 725 | - | - |
Financing Cash Flow | 2,905 | 3,134 | -3,025 | -1,761 | 34,712 | 1,766 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -459.74 | 546.94 | -433.48 | -4,696 | 3,960 | -12,469 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -3,725 | -2,731 | 1,954 | -2,932 | -30,995 | -13,524 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -24.82% | -41.20% | 30.58% | -12.90% | -82.13% | -17.84% |
Free Cash Flow Per Share | -2.38 | -1.75 | 1.25 | -1.88 | -22.57 | -10.82 |
Levered Free Cash Flow | 4,589 | 1,957 | 4,653 | 7,135 | -35,144 | -19,723 |
Unlevered Free Cash Flow | 5,043 | 2,378 | 4,954 | 7,550 | -34,670 | -19,610 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 726.06 | 672.71 | 482.4 | 663.42 | 759.2 | 180.42 |
Cash Income Tax Paid | 28.89 | 54.07 | -2,287 | - | 1,972 | 16,403 |